Moreover, other inflammatory markers such as IL-10 and IL-1β also demonstrated higher mean concentrations in severe COVID-19 patients (13.45 pg/mL and 14.78 pg/mL) compared with those with nonsevere symptoms (6.37 pg/mL and 6.91 pg/mL, respectively), with IL-10 showing a statistically significant reduction (p = 0.006), as presented in Table 3. The gene discussed is IL1B; the disease is COVID-19.